Clinical trial

A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda

NCT01371682

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-09-18

PhasePHASE1

Study timeline

Study start (actual)2009-09-18Date precision: day

Registry last updated2018-06-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

Ropinirole XLDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

AntwerpBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01371682 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.